SRF and hepatocellular carcinoma: The goal of our study was to improve the selectivity and potency of NS8593 to provide novel MRTF inhibitors for HCC therapy and new insights into the TRPM7-MRTF-A-SRF signaling pathway for therapeutic intervention.